More on SGMO
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.38 |
|
|||
| Open | $0.37 | ||||
| 52 Wk High | $9.91 | ||||
| 52 Wk Low | $3.10 | ||||
| Day High | $0.39 | ||||
| Day Low | $0.37 | ||||
| P/E | N/A | ||||
| EPS | $-0.48 | ||||
| Volume | 4,796,889 | ||||
- Form 4 SANGAMO THERAPEUTICS, For: Feb 24 Filed by: Macrae Sandy
- Form 4 SANGAMO THERAPEUTICS, For: Feb 24 Filed by: Dubois-Stringfellow Nathalie
- Form 4 SANGAMO THERAPEUTICS, For: Feb 24 Filed by: Jain Nikunj
- Form 4 SANGAMO THERAPEUTICS, For: Feb 24 Filed by: Davis Gregory D
- Form 4 SANGAMO THERAPEUTICS, For: Feb 24 Filed by: Willoughby Scott B.
- Form 8-K SANGAMO THERAPEUTICS, For: Feb 03
- Form 424B5 SANGAMO THERAPEUTICS,
- Form 8-K SANGAMO THERAPEUTICS, For: Feb 03
- Sangamo presents Fabry disease gene therapy data at medical symposium
- Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026
Entities mentioned with SGMO
- Earnings | View Related Stories »
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Jefferies & Co | View Related Stories »
- Wells Fargo | View Related Stories »
- Cowen & Co | View Related Stories »
- Show More...
